Fresenius SE & Co KGaA Market capitalization 2024

The Fresenius SE & Co KGaA Market capitalization history

YEAR	REVENUE (undefined EUR)	GROSS MARGIN (%)	NET INCOME (undefined EUR)
2028e	27.53	18,37	2.49
2027e	26.59	19,02	2.32
2026e	29.44	17,18	2.13
2025e	27.83	18,18	1.95
2024e	25.5	19,83	1.68
2023	22.3	22,68	-0.59
2022	21.53	25,09	1.37
2021	37.52	27,48	1.82
2020	36.28	28,44	1.71
2019	35.41	29,22	1.88
2018	33.53	29,33	2.03
2017	33.89	30,96	1.81
2016	29.47	32,28	1.56
2015	28	31,87	1.39
2014	23.46	30,15	1.07
2013	20.55	32,13	0.99
2012	19.51	33,37	0.93
2011	16.52	34,13	0.69
2010	15.97	33,33	0.62
2009	14.17	32,79	0.48
2008	12.35	31,92	0.53
2007	11.39	32,52	0.42
2006	10.78	31,89	0.33
2005	7.89	34,09	0.22
2004	7.27	32,68	0.17

Fresenius SE & Co KGaA Aktienanalyse

What does Fresenius SE & Co KGaA do?

Fresenius SE is a German pharmaceutical and medical technology company, which was founded in 1912 by Eduard Fresenius. The company's history is marked by continuous growth and numerous acquisitions, which have shaped the current corporate structure. Fresenius operates in four different divisions: Fresenius Medical Care is a global leader in dialysis treatment and offers products as well as services related to dialysis. Fresenius Kabi specializes in the production of medications and medical devices for infusion and nutrition therapy. Fresenius Helios is one of the largest providers of hospital treatments with over 110 clinics and operates facilities in Germany, Spain, and Latin America. Fresenius Vamed offers services related to the management and planning of healthcare facilities and operates worldwide in over 85 countries. The business model of Fresenius SE is based on the development and production of innovative medical products, as well as the provision of services in the healthcare sector. The company relies on high-quality products and intensive research and development. A key factor for success is focusing on the needs of customers and patients to ensure the best possible care. One of the most well-known products of Fresenius SE are the Fresenius concentrates for dialysis treatment. These enable effective and gentle blood cleansing, thereby improving the quality of life for dialysis patients. Another example of innovative products are the 3-in-1 infusion systems by Fresenius Kabi. These combine the administration of fluids, medications, and nutrition into one system, offering significantly higher efficiency in patient care. Fresenius Helios focuses on patient-centered care and offers a wide range of medical services. The company operates both acute care clinics and long-term care facilities and utilizes state-of-the-art technologies to improve diagnosis and treatment. Fresenius Vamed provides its customers with services such as facility management, planning, and project management for healthcare facilities, as well as operational consulting. The comprehensive expertise in all areas of the healthcare industry ensures high quality in the implementation of construction projects and renovations. In summary, Fresenius SE is an internationally active company specializing in the provision of high-quality products and services in the healthcare sector. The company focuses on patient-centered care and the continuous development of innovative products and technologies. Fresenius SE & Co KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius SE & Co KGaA revenue by segment

In the annual report of the Fresenius SE & Co KGaA share (DE0005785604, 578560, FRE.DE), it breaks down its revenues into 4 segments: 1. Helios, 2. Kabi, 3. Vamed, 4. Medical Care. The Fresenius SE & Co KGaA stock (WKN: 578560, ISIN: DE0005785604, Ticker Symbol: FRE.DE) is a leading investment for investors interested in participating in the Health Care sector.

Market capitalization Details

Exploring Fresenius SE & Co KGaA's Market Capitalization

Fresenius SE & Co KGaA's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Fresenius SE & Co KGaA's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Fresenius SE & Co KGaA's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Fresenius SE & Co KGaA’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Fresenius SE & Co KGaA Stock

What is the current Fresenius SE & Co KGaA market capitalization?

The current market capitalization of Fresenius SE & Co KGaA is 15.79 B EUR.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Fresenius SE & Co KGaA.

How has the market capitalization of Fresenius SE & Co KGaA developed in recent years?

The market capitalization of Fresenius SE & Co KGaA has increased/decreased by 3.76% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Fresenius SE & Co KGaA?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Fresenius SE & Co KGaA?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Fresenius SE & Co KGaA have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Fresenius SE & Co KGaA pay?

Over the past 12 months, Fresenius SE & Co KGaA paid a dividend of 0.92 EUR . This corresponds to a dividend yield of about 3.28 %. For the coming 12 months, Fresenius SE & Co KGaA is expected to pay a dividend of 0.96 EUR.

What is the dividend yield of Fresenius SE & Co KGaA?

The current dividend yield of Fresenius SE & Co KGaA is 3.28 %.

When does Fresenius SE & Co KGaA pay dividends?

Fresenius SE & Co KGaA pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA paid dividends every year for the past 25 years.

What is the dividend of Fresenius SE & Co KGaA?

For the upcoming 12 months, dividends amounting to 0.96 EUR are expected. This corresponds to a dividend yield of 3.43 %.

In which sector is Fresenius SE & Co KGaA located?

Fresenius SE & Co KGaA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fresenius SE & Co KGaA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fresenius SE & Co KGaA from 5/22/2023 amounting to 0.92 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2023.

When did Fresenius SE & Co KGaA pay the last dividend?

The last dividend was paid out on 5/22/2023.

What was the dividend of Fresenius SE & Co KGaA in the year 2023?

In the year 2023, Fresenius SE & Co KGaA distributed 0.66 EUR as dividends.

In which currency does Fresenius SE & Co KGaA pay out the dividend?

The dividends of Fresenius SE & Co KGaA are distributed in EUR.